Five Central Massachusetts life sciences companies are splitting $5 million in tax incentives to create 245 jobs in the region.
Already a Subscriber? Log in
Get Instant Access to This Article
Subscribe to Worcester Business Journal and get immediate access to all of our subscriber-only content and much more.
- Critical Central Massachusetts business news updated daily.
- Immediate access to all subscriber-only content on our website.
- Bi-weekly print or digital editions of our award-winning publication.
- Special bonus issues like the WBJ Book of Lists.
- Exclusive ticket prize draws for our in-person events.
Click here to purchase a paywall bypass link for this article.
Five Central Massachusetts life sciences companies are splitting $5 million in tax incentives to create 245 jobs in the region.
The tax incentives are provided through the Massachusetts Life Sciences Center’s Tax Incentive program, which awarded $17.3 million in incentives to a total of 25 Massachusetts companies pledging to create a combined 806 life sciences positions, according to a Thursday press release from the Massachusetts Executive Office of Economic Development.
Three of the five Central Massachusetts recipients are among the region’s largest life sciences and biotech companies.
AbbVie, an Illinois-based biopharmaceutical firm with a large Worcester presence, received the largest sum of tax incentives, having been awarded $1.53 million to create 60 jobs.
Repligen Corp., a biotech company out of Hopkinton, pledged to create 63 jobs, the most of all five firms, with its awarded $1.32 million in incentives.
The three other Central Massachusetts firms receiving incentives are:
- IPG Medical Corp. in Marlborough received $975,000 to create 50 jobs.
- Insulet in Acton received $738,000 to create 41 jobs.
- Karl Storz Endovision in Franklin received $713,000 to create 321 jobs.